Global Pivotal Phase 2 Trial of the CD19-Targeted Therapy CTL019 In Adult Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)—An Interim Analysis
Stephen J. Schuster,Michael Bishop,Constantine S. Tam,Edmund K. Waller,Peter Borchmann,Joseph P. McGuirk,Ulrich Jäger,Samantha Jaglowski,Charalambos Andreadis,Jason R. Westin,Isabelle Fleury,Veronika Bachanová,S.R. Foley,P. Joy Ho,Stephan Mielke,John Magenau,Harald Holte,Oezlem Anak,Lida Pacaud,Rakesh Awasthi